Mechanistic Multiscale Co-crystal Dissolution Modelling

机械多尺度共晶溶解建模

基本信息

  • 批准号:
    EP/V047329/1
  • 负责人:
  • 金额:
    $ 25.79万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2021
  • 资助国家:
    英国
  • 起止时间:
    2021 至 无数据
  • 项目状态:
    已结题

项目摘要

Dissolution of active pharmaceutical ingredients (APIs) in orally administrated drug products (such as tablets and capsules) is a pre-requisite for absorption within the human body because only dissolved drug molecules are able to diffuse through living tissues. Poorly soluble drugs can lead to a low dissolution rate and poor bioavailability. Therefore, the preparation of less conventional solid forms and more innovative formulation strategies are needed. In this work we aim to address improving the oral bioavailability of poorly soluble drugs using co-crystals, which are defined as bringing an API and one or more other molecular species (called co-formers) in stoichiometric amounts to form a crystal lattice. The advantage of co-crystals is to improve the API solubility, dissolution rate, physical and chemical stability as well as in mechanical properties. Therefore, co-crystallisation of APIs can offer a means of improving the oral bioavailability of poorly soluble drugs without compromising their pharmacological activity. For a single component crystalline compound, the dissolution transient typically terminates when the solubility limit of the drug is reached, with the solution concentration being maintained as long as the system thermodynamics remain unperturbed. In this situation, the rates of dissolution and precipitation are in dynamic equilibrium. However, the understanding of dissolution mechanisms of multi-component co-crystals is very limited. It has been observed that the dissolution of co-crystals can lead to solution-mediated phase transformation (SMPT) where precipitation of the parent drug could take place on the surface of the dissolving co-crystal and/or in the bulk solution due to the "spring" effect where the parent drug solution concentration exceeds that of the crystal. The rates of these two processes, working in opposing directions, define the magnitude and duration of the solubility-enhanced "parachute", that can have direct implications on the drug bioavailability. Therefore, characterizing the recrystallization kinetics is of importance for predicting in vitro and in vivo performance of co-crystals. Additionally, stabilizing (nucleation and growth inhibiting) polymers are normally present within a formulation or in the dissolution medium to delay drug precipitation for maximising the benefits of co-crystals. The kinetics of the solution de-supersaturation event are often much more complex and less well understood. For this reason, through modelling such behaviour we can significantly reduce the experimental burden required to characterize the "spring" and "parachute" effects. Furthermore, through our mechanistic modelling of co-crystal dissolution we will facilitate the development and leverage of clinically relevant dissolution specifications (CRS) and play a key role in the successful prediction of clearance in vivo within physiologically-based pharmacokinetic (PBPK) modelling.
口服药物产品(如片剂和胶囊)中活性药物成分(API)的溶解是人体吸收的先决条件,因为只有溶解的药物分子才能通过活组织扩散。难溶性药物可导致低溶出速率和差的生物利用度。因此,需要制备不太常规的固体形式和更创新的制剂策略。在这项工作中,我们的目标是解决使用共晶体改善难溶性药物的口服生物利用度,共晶体被定义为使API和一种或多种其他分子种类(称为共形成物)以化学计量的量形成晶格。共晶的优点是改善了API的溶解度、溶出速率、物理和化学稳定性以及机械性能。因此,API的共结晶可以提供一种改善难溶性药物的口服生物利用度而不损害其药理活性的方法。对于单组分结晶化合物,溶解瞬态通常在达到药物的溶解度极限时终止,只要系统热力学保持不受干扰,溶液浓度就保持不变。在这种情况下,溶解和沉淀的速率处于动态平衡。然而,对多组分共晶的溶解机理的理解非常有限。已经观察到,共晶体的溶解可以导致溶液介导的相转化(SMPT),其中由于“弹簧”效应,母体药物溶液的浓度超过晶体的浓度,母体药物的沉淀可以发生在溶解的共晶体的表面上和/或本体溶液中。这两个过程的速率,在相反的方向上工作,定义了溶解度增强的“降落伞”的大小和持续时间,这可能对药物生物利用度有直接的影响。因此,表征共晶的重结晶动力学对于预测共晶的体内外性能具有重要意义。此外,稳定(成核和生长抑制)聚合物通常存在于制剂中或溶出介质中以延迟药物沉淀,从而使共晶的益处最大化。溶液去过饱和事件的动力学通常要复杂得多,也不太清楚。由于这个原因,通过模拟这种行为,我们可以显着减少所需的实验负担,以表征“弹簧”和“降落伞”的影响。此外,通过我们对共晶溶出的机制建模,我们将促进临床相关溶出质量标准(CRS)的开发和利用,并在基于生理学的药代动力学(PBPK)建模中成功预测体内清除率方面发挥关键作用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nucleation of Supersaturated Flufenamic Acid Cocrystal Solutions in the Presence of a Polymer
  • DOI:
    10.1021/acs.cgd.2c00323
  • 发表时间:
    2022-08-12
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Alinda, Peace;Shi, Kejing;Li, Mingzhong
  • 通讯作者:
    Li, Mingzhong
Optimisation of Pharmaceutical Cocrystal Dissolution Performance through a Synergistic Precipitation Inhibition.
  • DOI:
    10.1007/s11095-023-03532-x
  • 发表时间:
    2023-08
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Shi, Kejing;Li, Mingzhong
  • 通讯作者:
    Li, Mingzhong
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mingzhong Li其他文献

Pattern within a Fluidized Bed Granulator : by Full-Factorial Design of Fluidization Velocity and Particle Size
流化床造粒机内的模式:通过流化速度和粒度的全因子设计
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Huolong Liu;Seongkyu Yoon;Mingzhong Li
  • 通讯作者:
    Mingzhong Li
Ultrasound assistant chemotherapy may be a novel modality for solid tumors.
超声辅助化疗可能是治疗实体瘤的一种新方法。
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    H. Pan;Xiaopeng Ma;Mingzhong Li;JunZhang Chen;Hong Jiang
  • 通讯作者:
    Hong Jiang
Counteranion-Stabilized Titanium(IV) Isopolyoxocationic Clusters Isolated from Water
  • DOI:
    10.1021/acs.inorgchem.5b01901 %/ American Chemical Society
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Guanyun Zhang;Jie Hou;Mingzhong Li;Chen-Ho Tung;Yifeng Wang
  • 通讯作者:
    Yifeng Wang
Wide Input Range Supply Voltage Tolerant Capacitive Sensor Readout Using On-Chip Solar Cell
使用片上太阳能电池的宽输入范围电源电压耐受电容式传感器读数
  • DOI:
    10.1142/s0218126616400065
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Suyan Fan;M. Law;Mingzhong Li;Zhiyuan Chen;Chio;Pui;R. Martins
  • 通讯作者:
    R. Martins
Cell-sensitive phase contrast microscopy imaging by multiple exposures
通过多次曝光进行细胞敏感相差显微镜成像
  • DOI:
    10.1016/j.media.2015.04.011
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    10.9
  • 作者:
    Zhaozheng Yin;Hang Su;Dai Fei Elmer Ker;Mingzhong Li;Haohan Li
  • 通讯作者:
    Haohan Li

Mingzhong Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mingzhong Li', 18)}}的其他基金

Mechanistic Multiscale Modelling Of Drug Release from Immediate Release Tablets
速释片剂药物释放的机制多尺度建模
  • 批准号:
    EP/X032019/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Research Grant
Developing Patient Centric Oral Medicines for Neglected Tropical Diseases
开发以患者为中心的口服药物来治疗被忽视的热带疾病
  • 批准号:
    EP/R021198/1
  • 财政年份:
    2018
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Research Grant
In-Process Particle Sizing by Refractive Index Measurement
通过折射率测量进行过程中粒度测量
  • 批准号:
    EP/F007019/1
  • 财政年份:
    2008
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Research Grant

相似海外基金

CAREER: From Underground to Space: An AI Infrastructure for Multiscale 3D Crop Modeling and Assessment
职业:从地下到太空:用于多尺度 3D 作物建模和评估的 AI 基础设施
  • 批准号:
    2340882
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Continuing Grant
Multiscale Approaches And Scalability Within Climate Change-heritage Risk Assessments
气候变化遗产风险评估中的多尺度方法和可扩展性
  • 批准号:
    AH/Z000084/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Research Grant
Hybrid AI and multiscale physical modelling for optimal urban decarbonisation combating climate change
混合人工智能和多尺度物理建模,实现应对气候变化的最佳城市脱碳
  • 批准号:
    EP/X029093/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Fellowship
Mechanistic Multiscale Modelling Of Drug Release from Immediate Release Tablets
速释片剂药物释放的机制多尺度建模
  • 批准号:
    EP/X032019/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Research Grant
Advanced Multiscale Biological Imaging using European Infrastructures
利用欧洲基础设施进行先进的多尺度生物成像
  • 批准号:
    EP/Y036654/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Research Grant
Stuck in the mud: addressing the fine sediment conundrum with multiscale and interdisciplinary approaches to support global freshwater biodiversity
陷入困境:采用多尺度和跨学科方法解决细小沉积物难题,支持全球淡水生物多样性
  • 批准号:
    MR/Y020200/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Fellowship
Unravelling coupling between multiscale tissue mechanics and heart valve calcification
揭示多尺度组织力学与心脏瓣膜钙化之间的耦合
  • 批准号:
    EP/X027163/2
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Fellowship
Mechanistic Multiscale Modelling of Drug Release from Immediate Release Tablets
速释片剂药物释放的机制多尺度建模
  • 批准号:
    EP/X031969/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Research Grant
CAREER: Multiscale Bacterial Transport in Porous Media
职业:多孔介质中的多尺度细菌传输
  • 批准号:
    2340501
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Continuing Grant
CAREER: Anisotropy-Directed Synthesis of Optically Active 1D van der Waals Nanocrystals and Development of Multiscale Solid State Chemistry Educational Activities
职业:光学活性一维范德华纳米晶体的各向异性定向合成和多尺度固态化学教育活动的发展
  • 批准号:
    2340918
  • 财政年份:
    2024
  • 资助金额:
    $ 25.79万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了